SBIO.L vs. IHCU.L
SBIO.L (Invesco Nasdaq Biotech UCITS ETF) and IHCU.L (iShares S&P 500 Health Care Sector UCITS ETF USD (Acc)) are both Health & Biotech Equities funds - SBIO.L tracks the NASDAQ Biotechnology TR USD while IHCU.L tracks the iShares S&P 500 Health Care Sector UCITS ETF USD (Acc). Both are passively managed. Over the past 10 years, SBIO.L returned 8.95%/yr vs 9.54%/yr for IHCU.L. A 0.64 correlation means they provide meaningful diversification when combined. SBIO.L charges 0.40%/yr vs 0.15%/yr for IHCU.L.
Performance
SBIO.L vs. IHCU.L - Performance Comparison
Loading charts...
Different Trading Currencies
SBIO.L is traded in USD, while IHCU.L is traded in GBp. To make them comparable, the IHCU.L values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, SBIO.L achieves a 14.76% return, which is significantly higher than IHCU.L's 3.24% return. Over the past 10 years, SBIO.L has underperformed IHCU.L with an annualized return of 8.95%, while IHCU.L has yielded a comparatively higher 9.54% annualized return.
SBIO.L
- 1D
- 0.44%
- 1M
- 9.18%
- 6M
- 12.82%
- YTD
- 14.76%
- 1Y
- 49.55%
- 3Y*
- 17.44%
- 5Y*
- 5.79%
- 10Y*
- 8.95%
IHCU.L
- 1D
- 0.00%
- 1M
- 4.56%
- 6M
- 2.21%
- YTD
- 3.24%
- 1Y
- 21.72%
- 3Y*
- 8.23%
- 5Y*
- 5.83%
- 10Y*
- 9.54%
SBIO.L vs. IHCU.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SBIO.L Invesco Nasdaq Biotech UCITS ETF | 14.76% | 32.89% | -2.00% | 6.15% | -11.85% | -0.49% | 27.35% | 25.54% | -11.34% | 21.45% |
IHCU.L iShares S&P 500 Health Care Sector UCITS ETF USD (Acc) | 3.24% | 14.83% | 2.22% | 1.18% | -2.66% | 27.98% | 11.40% | 21.58% | 4.18% | 21.90% |
Correlation
The correlation between SBIO.L and IHCU.L is 0.62, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.62 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.57 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.59 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.63 |
Correlation (All Time) Calculated using the full available price history since Nov 20, 2015 | 0.64 |
The correlation between SBIO.L and IHCU.L has been stable across timeframes, ranging from 0.57 to 0.64 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SBIO.L vs. IHCU.L — Risk / Return Rank
SBIO.L
IHCU.L
SBIO.L vs. IHCU.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco Nasdaq Biotech UCITS ETF (SBIO.L) and iShares S&P 500 Health Care Sector UCITS ETF USD (Acc) (IHCU.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SBIO.L | IHCU.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.03 | ||
| Sortino ratioReturn per unit of downside risk | +1.21 | ||
| Omega ratioGain probability vs. loss probability | 1.39 | 1.24 | +0.15 |
| Calmar ratioReturn relative to maximum drawdown | 6.45 | 2.00 | +4.44 |
| Martin ratioReturn relative to average drawdown | 19.17 | 4.97 | +14.20 |
Loading charts...
Drawdowns
SBIO.L vs. IHCU.L - Drawdown Comparison
The maximum SBIO.L drawdown since its inception was -39.44%, roughly equal to the maximum IHCU.L drawdown of -41.33%. Use the drawdown chart below to compare losses from any high point for SBIO.L and IHCU.L.
Loading charts...
Drawdown Indicators
| SBIO.L | IHCU.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -39.44% | -41.33% | +1.89% |
Max Drawdown (1Y)Largest decline over 1 year | -7.65% | -10.55% | +2.90% |
Max Drawdown (3Y)Largest decline over 3 years | -26.89% | -19.50% | -7.39% |
Max Drawdown (5Y)Largest decline over 5 years | -38.33% | -19.50% | -18.83% |
Max Drawdown (10Y)Largest decline over 10 years | -38.33% | -27.15% | -11.18% |
Current DrawdownCurrent decline from peak | -4.15% | -3.08% | -1.07% |
Average DrawdownAverage peak-to-trough decline | -16.68% | -12.57% | -4.11% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.58% | 4.27% | -1.69% |
Volatility
SBIO.L vs. IHCU.L - Volatility Comparison
Invesco Nasdaq Biotech UCITS ETF (SBIO.L) has a higher volatility of 6.42% compared to iShares S&P 500 Health Care Sector UCITS ETF USD (Acc) (IHCU.L) at 5.42%. This indicates that SBIO.L's price experiences larger fluctuations and is considered to be riskier than IHCU.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SBIO.L | IHCU.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.42% | 5.42% | +1.00% |
Volatility (6M)Calculated over the trailing 6-month period | 15.51% | 11.35% | +4.16% |
Volatility (1Y)Calculated over the trailing 1-year period | 20.35% | 15.09% | +5.26% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.26% | 20.58% | +0.68% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.15% | 18.62% | +3.53% |
SBIO.L vs. IHCU.L - Expense Ratio Comparison
SBIO.L has a 0.40% expense ratio, which is higher than IHCU.L's 0.15% expense ratio.
Dividends
SBIO.L vs. IHCU.L - Dividend Comparison
Neither SBIO.L nor IHCU.L has paid dividends to shareholders.
Frequently Asked Questions
SBIO.L and IHCU.L have a correlation of 0.62, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, IHCU.L is cheaper at 0.15% per year. The better choice depends on whether you care most about return, fees, risk, or income.
IHCU.L is cheaper with a 0.15% expense ratio, compared with 0.40% for SBIO.L.
SBIO.L tracks NASDAQ Biotechnology TR USD, while IHCU.L tracks iShares S&P 500 Health Care Sector UCITS ETF USD (Acc). They also come from different issuers: Invesco and iShares. Their fees differ too: 0.40% for SBIO.L and 0.15% for IHCU.L.
Find the right allocation for SBIO.L and IHCU.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer